Planet Labs PBC (NYSE: PL) releases Q3 2025 results and schedules call

Rhea-AI Filing Summary

Planet Labs PBC announced its financial results for the third fiscal quarter ended October 31, 2025. The company also scheduled a conference call and webcast to discuss these results at 5:00 p.m. Eastern time on December 10, 2025. A press release containing the detailed quarterly results is attached as Exhibit 99.1 and incorporated by reference, while the information is furnished rather than filed under securities law, limiting certain legal liabilities.

8-K Event Classification

2 items: 2.02, 9.01

2 items

Item 2.02 Results of Operations and Financial Condition Financial

Disclosure of earnings results, typically an earnings press release or preliminary financials.

Item 9.01 Financial Statements and Exhibits Exhibits

Financial statements, pro forma financial information, and exhibit attachments filed with this report.

Understanding 8-K Material Events →

0001836833false0001836833us-gaap:CommonStockMember2025-12-102025-12-100001836833pl:WarrantsToPurchaseClassACommonStockAtAnExercisePriceOf1150PerShareMember2025-12-102025-12-1000018368332025-12-102025-12-10

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): December 10, 2025

Planet Labs PBC

(Exact name of Registrant as Specified in Its Charter)

California			001-40166	85-4299396
(State or Other Jurisdiction of Incorporation)			(Commission File Number)	(IRS Employer Identification No.)
645 Harrison Street, Floor 4
San Francisco, California				94107
(Address of Principal Executive Offices)				(Zip Code)

Registrant’s Telephone Number, Including Area Code: 415 829-3313

N/A

(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class		Trading Symbol(s)		Name of each exchange on which registered
Class A Common Stock, par value $0.0001 per share		PL		New York Stock Exchange
Warrants to purchase Class A Common Stock, at an exercise price of $11.50 per share		PL WS		New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 2.02 Results of Operations and Financial Condition.

On December 10, 2025, Planet Labs PBC (the “Company”) issued a press release announcing its financial results for its third fiscal quarter ended October 31, 2025. The Company announced that it will hold a conference call and webcast to discuss these results at 5:00 p.m. eastern time on December 10, 2025. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated by reference herein.

The information in this Item 2.02, including the information contained in Exhibit 99.1, of this Current Report on Form 8-K is furnished herewith and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities under that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, regardless of any general incorporation language in such filing.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits

Exhibit Number		Exhibit Description
99.1		Press Release of Planet Labs PBC dated December 10, 2025
104		Cover Page Interactive Data File - the cover page XBRL tags are embedded within the Inline XBRL document

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

			Planet Labs PBC
Date:	December 10, 2025	By:	/s/ Ashley Johnson
			Ashley Johnson President and Chief Financial Officer

FAQ

What did Planet Labs PBC (PL) announce in this 8-K?

Planet Labs PBC announced that it has released its financial results for the third fiscal quarter ended October 31, 2025, via a press release attached as Exhibit 99.1.

Which fiscal period does Planet Labs PBC’s latest results cover?

The results cover Planet Labs PBC’s third fiscal quarter ended October 31, 2025.

Is Planet Labs PBC holding an earnings call for the October 31, 2025 quarter?

Yes. Planet Labs PBC will hold a conference call and webcast to discuss its third fiscal quarter 2025 results at 5:00 p.m. Eastern time on December 10, 2025.

Where can investors find the detailed Q3 2025 results for Planet Labs PBC (PL)?

The detailed third fiscal quarter 2025 results are provided in the press release attached as Exhibit 99.1 to this report and incorporated by reference.

How is the financial information in this Planet Labs PBC 8-K treated under securities law?

The information under Item 2.02, including Exhibit 99.1, is furnished and not deemed filed for purposes of Section 18 of the Securities Exchange Act of 1934.

What securities of Planet Labs PBC are listed on the NYSE?

Planet Labs PBC lists its Class A Common Stock, par value $0.0001 per share, under the symbol PL and its warrants to purchase Class A Common Stock at an exercise price of $11.50 per share under the symbol PL WS on the New York Stock Exchange.